These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

118 related articles for article (PubMed ID: 7726750)

  • 1. [Effect of fog on diurnal changes in peak expiratory flow rates in an asthmatic].
    Tanaka H; Honma S; Imada A; Sugaya F; Nishi M; Abe S
    Arerugi; 1995 Feb; 44(2):64-9. PubMed ID: 7726750
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effects of naturally-occurring acid fog on inflammatory mediators in airway and pulmonary functions in asthmatic patients.
    Honma S; Tanaka H; Teramoto S; Igarashi T; Abe S
    Respir Med; 2000 Oct; 94(10):935-42. PubMed ID: 11059945
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Diurnal variation in peak expiratory flow in asthmatics.
    Bagg LR; Hughes DT
    Eur J Respir Dis; 1980 Oct; 61(5):298-302. PubMed ID: 7193594
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The normal range of diurnal changes in peak expiratory flow rates. Relationship to symptoms and respiratory disease.
    Quackenboss JJ; Lebowitz MD; Krzyzanowski M
    Am Rev Respir Dis; 1991 Feb; 143(2):323-30. PubMed ID: 1990947
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Omeprazole improves peak expiratory flow rate and quality of life in asthmatics with gastroesophageal reflux.
    Levin TR; Sperling RM; McQuaid KR
    Am J Gastroenterol; 1998 Jul; 93(7):1060-3. PubMed ID: 9672330
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Study by questionnaire of the influence of weather conditions, particularly fog, on the symptomatology of asthmatic subjects].
    Kopferschmitt-Kübler MC; Blaumeiser-Kapps M; Millet M; Wortham H; Mirabel P; Nobelis P; Pauli G
    Rev Mal Respir; 1996; 13(4):421-7. PubMed ID: 8878363
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Dose response to inhaled terbutaline powder and peak inspiratory flow through Turbuhaler in children with mild to moderate asthma.
    Ståhl E; Ribeiro LB; Sandahl G
    Pediatr Pulmonol; 1996 Aug; 22(2):106-10. PubMed ID: 8875584
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Relationship between peak expiratory flow rate and shoulders posture in healthy individuals and moderate to severe asthmatic patients.
    Robles-Ribeiro PG; Ribeiro M; Lianza S
    J Asthma; 2005 Nov; 42(9):783-6. PubMed ID: 16316874
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Circadian rhythm of peak expiratory flow rate in healthy north Indian men.
    Goyal M; Goel A; Kumar P; Bajpai M; Verma NS; Kant S; Tiwari S
    Indian J Physiol Pharmacol; 2008; 52(1):64-8. PubMed ID: 18831353
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Pulmonary function and airway responsiveness in mild to moderate asthmatics given repeated inhaled doses of zanamivir.
    Cass LM; Gunawardena KA; Macmahon MM; Bye A
    Respir Med; 2000 Feb; 94(2):166-73. PubMed ID: 10714424
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Symptoms and peak expiratory flow rate: diurnal variation in asthmatic children.
    Ho TF; Ngiam TE
    J Singapore Paediatr Soc; 1981; 23(1-2):42-6. PubMed ID: 7201045
    [No Abstract]   [Full Text] [Related]  

  • 12. Effects of self-efficacy, social support and knowledge on adherence to PEFR self-monitoring among adults with asthma: a prospective repeated measures study.
    Ngamvitroj A; Kang DH
    Int J Nurs Stud; 2007 Aug; 44(6):882-92. PubMed ID: 16620821
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Adequacy of control of asthma in a general practice. Is maximum peak expiratory flow rate a valid index of asthma severity?
    Morris NV; Abramson MJ; Strasser RP
    Med J Aust; 1994 Jan; 160(2):68-71. PubMed ID: 8309371
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A randomized, clinical trial comparing the efficacy of continuous nebulized albuterol (15 mg) versus continuous nebulized albuterol (15 mg) plus ipratropium bromide (2 mg) for the treatment of acute asthma.
    Salo D; Tuel M; Lavery RF; Reischel U; Lebowitz J; Moore T
    J Emerg Med; 2006 Nov; 31(4):371-6. PubMed ID: 17046476
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Initial treatment of symptomatic mild to moderate bronchial asthma with the salmeterol/fluticasone propionate (50/250 microg) combination product (SAS 40023).
    Baumgarten C; Geldszus R; Behre U; Peslis N; Trautmann M;
    Eur J Med Res; 2002 Jan; 7(1):1-7. PubMed ID: 11827834
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Asthma, bronchial hyperreactivity and mediator release in children with birch pollinosis. ECP and EPX levels are not related to bronchial hyperreactivity.
    Ferdousi HA; Dreborg S
    Clin Exp Allergy; 1997 May; 27(5):530-9. PubMed ID: 9179427
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effects of personal particulate matter on peak expiratory flow rate of asthmatic children.
    Tang CS; Chang LT; Lee HC; Chan CC
    Sci Total Environ; 2007 Aug; 382(1):43-51. PubMed ID: 17521708
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Health effects of ultraviolet irradiation in asthmatic children's homes.
    Bernstein JA; Bobbitt RC; Levin L; Floyd R; Crandall MS; Shalwitz RA; Seth A; Glazman M
    J Asthma; 2006 May; 43(4):255-62. PubMed ID: 16809237
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Diurnal variation of peak expiratory flow rate in asthmatic children.
    Sly PD; Hibbert ME; Landau LI
    Pediatr Pulmonol; 1986; 2(3):141-6. PubMed ID: 3737275
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [A study on peak expiratory flow monitoring maneuver as compared to forced expiratory flow maneuver].
    Nagasaka Y; Fujita E; Hazu R; Nishimura N; Nakajima S
    Arerugi; 1996 Jan; 45(1):34-40. PubMed ID: 8851314
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.